ApoE, Alzheimer's and Lipoprotein Biology
joint with Clinical and Molecular Biology of Acute and Chronic Traumatic Encephalopathies
Organizer(s): Joachim Herz, David M. Holtzman and Eric M. ParkerDate: February 26 - March 02, 2012
Location: Keystone Resort, Keystone, CO, USA
Apolipoprotein E4 (ApoE4) genotype is the primary risk factor for late-onset Alzheimer’s Disease. Approximately one fifth of the human population are ApoE4 carriers, yet more than 17 years after its discovery, the molecular basis by which this common allele causes neurodegeneration is still not understood. One major reason is the lack of effective communication between lipid researchers who have investigated the role of ApoE as a plasma lipid transport protein, and neuroscientists who are unfamiliar with the complex biochemistry of lipid metabolism and the cell biology of ApoE receptors. This is confounded by the methodological difficulty of studying lipid metabolism and lipoprotein transport in the brain and the paucity of pioneering work tackling this problem. Yet, the solution to one of the most pressing socioeconomic problems of our times, the looming Alzheimer’s Disease epidemic, depends on our ability to dissect and understand the molecular mechanism by which ApoE4 is causing this disease. The purpose of this highly interdisciplinary meeting on ApoE, Alzheimer’s and lipoprotein biology is to bring together a critical mass of experts with complementary expertise from these different fields, but who do not normally collaborate or attend the same conferences. In this manner, we envisage this meeting serving as the main catalyst for communication and collaboration between lipid and lipoprotein researchers, neurogeneticists, cell biologists and synaptic neurophysiologists. Opportunities for interdisciplinary interactions will be significantly enhanced by the concurrent conference on Clinical and Molecular Biology of Acute and Chronic Traumatic Encephalopathies, which will share opening keynote addresses and a fourth day of sessions with this meeting.
Scholarship Deadline: October 26 2011
Discounted Abstract Deadline: October 26 2011
Abstract Deadline: December 2 2011
Discounted Registration Deadline: January 4 2012
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
Avid Radiopharmaceuticals, Inc.
Eli Lilly and Company
Merck & Co., Inc.
We gratefully acknowledge the generous grant for this conference provided by:National Institute on Aging (NIA)
Grant No. 1R13AG041542-01
The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.